Crescent Biopharma Inc.
CBIO | NASDAQ
$12.89
-$0.59 (-4.38%)
Nov 2, 2026, 1:16 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.80 | -0.39 | -4.05 | -3.41 | -1.17 | -3.37 |
PEG Ratio | 0.01 | -0.05 | 0.12 | 0.12 | -0.11 | 0.20 |
PS Ratio | 11.39 | n/a | 14.95K | 2.12K | 63.89 | 16.92 |
PB Ratio | 0.61 | -1.23 | 3.89 | 3.71 | 0.91 | 1.34 |
P/FCF Ratio | -0.86 | -0.61 | -4.28 | -3.42 | -1.29 | -4.37 |
P/OCF Ratio | -1.73 | -0.61 | -4.29 | -3.43 | -1.29 | -4.38 |
OCF/S Ratio | -659.65 | n/a | -348.8K | -61.94K | -4.96K | -386.13 |
Debt / Equity Ratio | 0.01 | -2.42 | 0.02 | 0.02 | 0.02 | 0.02 |
Quick Ratio | 6.56 | 3.62 | 6.41 | 5.71 | 7.68 | 11.13 |
Current Ratio | 6.56 | 3.62 | 6.41 | 5.71 | 7.68 | 11.13 |
Asset Turnover | 0.05 | n/a | 0 | 0 | 0.01 | 0.07 |
Interest Coverage | -69.85 | -58.57 | n/a | n/a | n/a | n/a |
Return on Equity | -75.83% | 313.48% | -96.06% | -108.76% | -77.73% | -39.80% |
Return on Assets | -64.06% | -136.24% | -81.43% | -90.11% | -67.23% | -35.73% |
Return on Invested Capital | -74.58% | -191.89% | -100.13% | -108.11% | -75.96% | -39.23% |
Dividend Yield | n/a | n/a | 10.17% | 47.19% | n/a | n/a |
Payout Ratio | n/a | n/a | -41.20% | -160.89% | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | n/a | 100% | 100% | 100% | 100% |
Net Profit Margin | -1.42K% | n/a | -368.99K% | -62.25K% | -5.47K% | -502.09% |
Pretax Profit Margin | -1.4K% | n/a | -368.99K% | -62.25K% | -5.47K% | -502.09% |
Operating Profit Margin | -1.41K% | n/a | -392.75K% | -63.2K% | -5.47K% | -506.84% |
FCF Margin | -1.33K% | n/a | -349.01K% | -62.06K% | -4.96K% | -386.80% |
EBITDA Margin | -1.38K% | n/a | -391.21K% | -62.93K% | -5.45K% | -504.17% |
Add to Watchlist
Select watchlists to add or remove CBIO